Skip to main content
Clinical Trials/NCT03395379
NCT03395379
Completed
Not Applicable

Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma

Centre Hospitalier Universitaire de Nice0 sites90 target enrollmentJanuary 11, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Unrecognized Condition
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment
90
Primary Endpoint
Failure rate of the air dissection procedure
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The investigators aimed to evaluate the feasibility and safety of using ambient air to protect against thermal injury during RadioFrequency Ablation (RFA) for Renal Cell Carcinoma (RCC) based on data from cases at their institute.

Detailed Description

The incidence of renal cell carcinoma (RCC) has been increasing, particularly among patients \>65 years of age. As older individuals are at higher risk for surgical complications, the use of radiofrequency ablation (RFA) for small renal masses (SRM) \<4 cm in size, which include T1a tumors,may be a compelling treatment option for elderly patients. However, RFA uses heat to destroy abnormal tissue, with the risk of thermal injury to tissues and organs, including gastric tissue and nerve roots, which are in proximity to the targeted treatment zone. The incidence rate of major complication with RFA, including thermal wounds, has been reported to vary between 3.2% and 5.2%. Different thermal protection methods have been developed to lower the risk of injury to adjacent tissues during ablation, such as air dissection using CO2 injection and hydrodissection using G5% for shielding. Although both of these options are effective, they are expensive. To lower the cost of thermal protection, the investigators have been using ambient air instead of CO2 for air dissection prior to RFA for SRM-RCCs.

Registry
clinicaltrials.gov
Start Date
January 11, 2012
End Date
May 15, 2016
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with Renal Cell Carcinoma (RCC)
  • Patients with a single SRM of \<4 cm, confirmed as RCC on biopsy
  • RCC status : pT1a
  • Eligible patients for an RadioFrequency Ablation (RFA) treatment

Exclusion Criteria

  • Patients who have already received a RFA treatment for an other tissu or tumor
  • Patients who have a bleeding tumor or prior local treatment

Outcomes

Primary Outcomes

Failure rate of the air dissection procedure

Time Frame: 6 weeks post-operative

The failure rate of the air dissection procedure is defined as the need for another dissection method, the inability to create sufficient space for successful dissection and/or damage to surrounding vital tissues.

Secondary Outcomes

  • Post-operative complications(6 weeks post-operative)

Similar Trials